Zimmer Biomet Holdings, Inc. (SWX:ZBH)
108.81
0.00 (0.00%)
At close: Jun 25, 2025
Zimmer Biomet Holdings Revenue
Zimmer Biomet Holdings had revenue of $1.91B USD in the quarter ending March 31, 2025, with 1.05% growth. This brings the company's revenue in the last twelve months to $7.70B, up 3.30% year-over-year. In the year 2024, Zimmer Biomet Holdings had annual revenue of $7.68B with 3.85% growth.
Revenue (ttm)
$7.70B
Revenue Growth
+3.30%
P/S Ratio
2.15
Revenue / Employee
$452.85K
Employees
17,000
Market Cap
14.64B CHF
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 7.68B | 284.40M | 3.85% |
Dec 31, 2023 | 7.39B | 454.30M | 6.55% |
Dec 31, 2022 | 6.94B | 112.60M | 1.65% |
Dec 31, 2021 | 6.83B | 699.80M | 11.42% |
Dec 31, 2020 | 6.13B | -1.85B | -23.24% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Roche Holding AG | 62.40B |
Novartis AG | 47.05B |
Lonza Group AG | 6.57B |
Alcon | 8.77B |
Galderma Group AG | 4.02B |
Sandoz Group AG | 9.41B |
Straumann Holding AG | 2.50B |
Sonova Holding AG | 3.87B |
Zimmer Biomet Holdings News
- 22 days ago - Zimmer Biomet sued for violating Treace Medical patents related to bunion treatment - Seeking Alpha
- 4 weeks ago - Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2025 - PRNewsWire
- 4 weeks ago - Zimmer Biomet Appoints Kevin Thornal as Group President, Global Businesses and the Americas - PRNewsWire
- 5 weeks ago - Zimmer Biomet to Present at the Goldman Sachs 46th Annual Global Healthcare Conference - PRNewsWire
- 5 weeks ago - We pay attention to policy and patients, says Zimmer Biomet CEO Ivan Tornos - CNBC
- 5 weeks ago - Arnold Schwarzenegger on aging and his new 'Terminator' technology mission for the good of humanity - CNBC
- 6 weeks ago - Anna Lapwood review – charismatic organist has a packed Royal Albert Hall eating out of her hand - The Guardian
- 7 weeks ago - These Analysts Lower Their Forecasts On Zimmer Biomet After Q1 Results - Benzinga